Amicus Therapeutics, Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

14.41

-0.02 (-0.14%)

At close: Mar 27, 2026, 4:00 PM EDT

14.44

+0.03 (0.19%)

After-hours: Mar 27, 2026, 7:42 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Galafold Revenue	521.70M	458.05M
Galafold Revenue Growth	13.89%	18.12%
Pombiliti and Opfolda Revenue	112.51M	70.24M
Pombiliti and Opfolda Revenue Growth	60.17%	506.62%
Revenue (Total)	634.21M	528.30M
Revenue (Total) Growth	20.05%	32.29%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Updated Dec 31, 2025. Data Source: Fiscal.ai.